CSRXP: GALLUP SURVEY FINDS NINE IN TEN AMERICANS WORRIED ABOUT RISING PRESCRIPTION DRUG PRICES

New Poll Underscores Need for Big Pharma to Suspend Summer Price Hikes and for Policymakers to Advance Market-Based Rx Pricing Solutions

Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) issued a statement Thursday after Gallup and West Health released a new poll that found nearly nine in 10 Americans are concerned Big Pharma will capitalize on the coronavirus crisis to hike prescription drug prices. The survey found more than half (55 percent) of Americans are “very concerned” about Big Pharma increasing drug prices.

“Rising prescription drug prices continue to be an urgent concern for the majority of Americans who are counting on policymakers to hold Big Pharma accountable,” said CSRxP executive director Lauren Aronson. “Americans rightly recognize Big Pharma’s track record of putting profits over people and Washington must respond by advancing market-based solutions to boost transparency, increase competition and stop drug companies’ price-gouging.”

“Big Pharma must also recognize it would be unacceptable to hike prescription drug prices at a time when millions of Americans face economic uncertainty and are concerned about the cost of their medications,” Aronson continued. “That is why Big Pharma must scrap biennial summer price hikes that would negatively impact the financial wellbeing and health care security of millions of Americans.”

Read more on the Gallup and West Health poll HERE.

Read more on CSRxP’s “No Price Hikes” campaign, and sign the petition urging Big Pharma to suspend biennial summer price increases HERE.